← Open Payments lookup

JOSEPH HOLLEY: Open Payments

NPI 1184077208 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,451 in 138 payments from 12 companies in 2025. Trend: 2023 $1,984 · 2024 $2,477 · 2025 $6,451

Food & beverage: $3,018Consulting: $2,616Travel & lodging: $817
CompanyPaymentsAmount
GENZYME CORPORATION17$3,848
ABBVIE INC.36$889
Madrigal Pharmaceuticals13$490
Janssen Biotech, Inc.16$310
Ardelyx, Inc.13$245
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$162
Takeda Pharmaceuticals U.S.A., Inc.8$152
Regeneron Healthcare Solutions, Inc.5$116
Phathom Pharmaceuticals, Inc.13$103
Gilead Sciences, Inc.2$50

Products named: REZDIFFRA, RINVOQ, DUPIXENT, SKYRIZI, TREMFYA, IBSRELA, ENTYVIO, XIFAXAN.

Industry payments across AL — which companies pay providers there.